Management of Infants at Risk for Group B Streptococcal Disease.

TitleManagement of Infants at Risk for Group B Streptococcal Disease.
Publication TypeJournal Article
Year of Publication2019
AuthorsPuopolo KM, Lynfield R, Cummings JJ
Corporate AuthorsCommittee on fetus and newborn, Committee on Infectious Diseases
JournalPediatrics
Date Published2019 Jul 08
ISSN1098-4275
Abstract

Group B streptococcal (GBS) infection remains the most common cause of neonatal early-onset sepsis and a significant cause of late-onset sepsis among young infants. Administration of intrapartum antibiotic prophylaxis is the only currently available effective strategy for the prevention of perinatal GBS early-onset disease, and there is no effective approach for the prevention of late-onset disease. The American Academy of Pediatrics joins with the American College of Obstetricians and Gynecologists to reaffirm the use of universal antenatal microbiologic-based testing for the detection of maternal GBS colonization to facilitate appropriate administration of intrapartum antibiotic prophylaxis. The purpose of this clinical report is to provide neonatal clinicians with updated information regarding the epidemiology of GBS disease as well current recommendations for the evaluation of newborn infants at risk for GBS disease and for treatment of those with confirmed GBS infection.

DOI10.1542/peds.2019-1881
Alternate JournalPediatrics
PubMed ID31285392